Literature DB >> 6391657

Role of first stimulating agents in the production of tumor necrosis factor.

K Haranaka, N Satomi, A Sakurai, R Haranaka.   

Abstract

The conditions and kinetics of tumor necrosis factor (TNF) production were examined. For TNF production, dual stimulation is necessary. Priming agents such as BCG, Corynebacterium parvum, and zymosan, which can stimulate the reticuloendothelial system (RES), are good substances for TNF production with the aid of lipopolysaccharide. Wide differences are observed in TNF producibility among different priming agents. The producibility of TNF depends on the degree of stimulation of the RES by the priming agents. Those priming agents, e.g., Propionibacterium acnes and Corynebacterium anaerobium, that are able to induce substantial RES hyperplasia are also able to induce high levels of TNF activity. Following administration of large doses of BCG or zymosan, mice were found to produce TNF activity. However, PPD, OK 432, PSK, and Choreito were unable to induce TNF activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391657     DOI: 10.1007/BF00205740

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  18 in total

1.  Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.

Authors:  L J OLD; D A CLARKE; B BENACERRAF
Journal:  Nature       Date:  1959-07-25       Impact factor: 49.962

2.  Tumor necrosis factor.

Authors:  L J Old
Journal:  Clin Bull       Date:  1976

3.  Vascular reactions of normal and malignant tissues in vivo. V. The rôle of hypotension in the action of a bacterial polysaccharide on tumors.

Authors:  G H ALGIRE; F Y LEGALLAIS; B F ANDERSON
Journal:  J Natl Cancer Inst       Date:  1952-06       Impact factor: 13.506

4.  Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).

Authors:  S Tsukagoshi; Y Sakurai; H Sato; S Akiba T SUZUKI
Journal:  Cancer Chemother Rep       Date:  1972-02

5.  Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes.

Authors:  M Saito; T Ebina; M Koi; T Yamaguchi; Y Kawade; N Ishida
Journal:  Cell Immunol       Date:  1982-03-15       Impact factor: 4.868

6.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

7.  Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.

Authors:  K Haranaka; N Satomi; A Sakurai
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

8.  Research on the production site of tumor necrosis factor (TNF).

Authors:  N Satomi; K Haranaka; O Kunii
Journal:  Jpn J Exp Med       Date:  1981-12

Review 9.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

Authors:  L J Old
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

10.  Effects of murine tumor necrosis factor on heterotransplanted human tumors.

Authors:  L Helson; C Helson; S Green
Journal:  Exp Cell Biol       Date:  1979
View more
  6 in total

1.  Tuftsin induced tumor necrosis activity.

Authors:  M S Wleklik; M Luczak; V A Najjar
Journal:  Mol Cell Biochem       Date:  1987-06       Impact factor: 3.396

2.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

3.  Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

Authors:  K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Tumor necrosis factor mediates endotoxic effects in mice.

Authors:  F Bauss; W Dröge; D N Männel
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Tumour necrosis factor and the lysosomal enzymes of macrophages or macrophage-like cell line.

Authors:  A Sakurai; N Satomi; K Haranaka
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs.

Authors:  K Haranaka; N Satomi; A Sakurai; R Haranaka; N Okada; M Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.